What are the risks of bleeding associated with continuing antiplatelet or anticoagulant medication during endoscopy?
The evidence shows that continuing antiplatelet or anticoagulant medications during endoscopy increases bleeding risk, but this must be balanced against thromboembolic risks associated with discontinuation. Individualized decision-making considering patient and procedural factors is crucial.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-04
- DOI
- https://doi.org/10.5281/zenodo.23943592
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00